Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Brainsway Ltd. Board/Management Information 2024

Aug 29, 2024

6701_rns_2024-08-29_609e9889-b94d-405e-a540-f39125b6f138.htm

Board/Management Information

Open in viewer

Opens in your device viewer

BrainsWay Appoints Richard A. Bermudes, M.D. as Chief Medical Officer false

���������� ��"� 2 380
BRAINSWAY LTD
Corporation no: 513890764 10767
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 27/08/2024
www.isa.gov.il www.tase.co.il Reference: 2024-02-094525 Time of broadcast: 13:38 13:38

The corporation scheduled the publication of the report to 29/08/2024 14:30Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onBrainsWay Appoints Richard A. Bermudes, M.D. as Chief Medical Officer

Brainsway_Appoints_Dr_Bermudes_CMO_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: BWAY Date of revision of form structure: 06/08/2024
Address: ����� 19 , ������� 91451   , Tel: 02-5813140 , Fax: 02-5812517
E-mail address: [email protected]   Company site: www.Brainsway.com
Previous names of reporting entity:
Name of the Signatory: Levy Hadar Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company:
Address: Hartum Street, Bynet Building 19 , Jerusalem 9777518 Telephone: 97225824030 Facsimile: 97225812517 E-mail: [email protected] 1